SALVAVEN - Peripheral Venous Catheter Clinical Trial - Prevention with Dermocosmetics EWMA 2023

Author and Speaker: Dr. Aurora Orlandini - San Raffaele Hospital, Milan, Italy

Study Topic:

Complications of chemotherapy administered via peripheral venous catheter and prevention with dermocosmetics

Purpose of the Study

The aim of this clinical trial was to prevent complications associated with chemotherapy, in particular chemical and traumatic phlebitis, in patients receiving treatment via peripheral venous access. The study tested the efficacy of the Oncos dermocosmetic Salvaven applied directly to the skin around the venous access.

Method used

Over a period of two years (September 2020 - September 2022), approximately 1000 patients were treated on a voluntary basis with Salvaven from Oncos throughout the entire period of chemotherapy administration via peripheral venous access.

The dermocosmetics were applied from the first to the last dose of chemotherapy. At each administration, the nurse assessed the condition of the skin and the venous structure.

Main results

The use of the dermocosmetic product Oncos Salvaven led to:

• A significant reduction in the incidence of phlebitis and skin complications associated with chemotherapy.
• A significant reduction in the extravasation of antineoplastic (anti-tumor) drugs.
• A lower need to establish central venous access due to damage to peripheral veins by repeated treatment.
• Possibilities for continuing treatment in patients in whom central venous access cannot be established or has been removed.

Study conclusions

The dermocosmetic product Salvaven from Oncos has proven to be an effective preventive agent in patients undergoing chemotherapy via the peripheral venous route. It helps reduce local side effects, protects the skin and subcutaneous veins, promotes regeneration and contributes to maintaining the elasticity and tone of the affected tissue. The result is increased patient comfort and improved quality of life during treatment.

Do you want to know more about the product Salvaven and its effects? See the detailed description at www.oncosderma.com or contact us for professional advice.